HONG KONG, Jan 28 (Reuters) - Ras Al Khaimah, one of seven city-states in the United Arab Emirates, is stepping up efforts to lure Chinese and Hong Kong investors into its real estate, green and ...

Judge says Greenpeace must pay $345 million in pipeline lawsuit, cutting jury amount nearly in half Mark Harmon to make rare 'NCIS: Origins' appearance and Gibbs is 'no longer alone' Why the White ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

If the AquaNor conference in Trondheim feels busier this year, we might have land-based aquaculture to thank. Investment in the industry exceeded $1.3 billion during the first half of 2025 and could ...

Pei Li was born in China and spent his teenage years in Australia, but it was France that really shaped his career. Having studied at university in the country, he went on to work for some of France’s ...

Description: Starting with geospatially attributed one-dimensional HEC-RAS floodplain models, these scripts are used to create a library of flood depth inundation rasters for a range of storm water ...

Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss or diabetes management doesn ’t raise the risk for adverse psychiatric events and improves quality of life (QOL) in ...

The federal trespassing charge against Newark Mayor Ras Baraka has been dismissed after his arrest outside an Immigration and Customs Enforcement facility, U.S. Attorney for New Jersey Alina Habba ...

Mark Prussin is a digital producer at CBS New York. He covers breaking news, sports, politics and trending stories in New York, New Jersey and Connecticut. Mark joined the CBS New York team in 2019.

Newark, New Jersey Mayor Ras Baraka was briefly arrested at an ICE detention center. The arrest occurred during an unannounced inspection by members of New Jersey's congressional delegation. Baraka, a ...

Erasca, Inc. presents promising preclinical data on ERAS-0015 and ERAS-4001 targeting RAS/MAPK pathway cancers at AACR meeting. Erasca, Inc. presented new preclinical data at the American Association ...

Erasca, Inc. announced significant progress in its RAS-targeting franchise, including the FDA's clearance of an investigational new drug application for ERAS-0015 and the submission of an IND ...